About Us
- Home
- About Onika Pharmaceuticals
The company's commitment to change the course of animal health through bold pursuits in science, life enhancing therapies and a promise to always put health first.
Passion, Innovation and courage have been in company's gene since inception. Our journey to a progressive company included unexpected road blocks, the courage of our people to convert those road blocks into opportunities and seize them. Our vision, is to not only overcome obstacles but to transform them into novel approaches & progress.
Prior to setting up ONIKA, Mr. G.K. Gupta (Chairman & CEO) had built up multidisciplinary experience in the pharmaceutical industry over a period of 40 years.
Onika started exploring overseas markets after the joining of Mr.Abhishek Gupta, M.Pharm. Prior to joining Onika, Mr. Abhishek worked with a reputed MNC as a research scientist and now working in developing / Uplifting ONIKA to a new level in export business.
Onika's research and development program identifies & evaluates natural compounds that shows the potential to advance the treatments of many diseases. We are focused on developing products with the ultimate goal to change the course of human health while promising to always put health first.
To support Onika in development programs we partnered with Catalyst Clinical Services an independent CRO based at New Delhi.
Onika has been committed to help, enrich lives globally by providing, affordable, bioavailable products that meets the most rigorous quality standards world wide. Quality is our priority. Our manufacturing facility and testing laboratory meets all the requirements of health care agencies around the world.
Good Manufacturing Practice (GMP) is a regulatory guideline imposed on all manufacturing of pharmaceuticals & herbal products to ensure that finished products have the identity, strength, quality & purity they are required to have.
Onika currently markets more than 60 generic formulations in India, covering a wide range of therapeutic segments. Our products have been widely acceptance and have marked its presence in more than 20 states in India.
Onika is focused on drug safety, monitoring & evaluations throughout all stages of our product life cycle. We are also committed to the safe & efficacious use of our products. If you experience any unanticipated side effects or have a complaint about our products, please contact,
From within India,
To report adverse event, product complaints, or for product / medical related questions related with Onika products call +91 (184) 2205001, +91 (184) 2205002
From outside India,
To report adverse events and product complaints please contact Marketing Authorization Holder for the product. Contact details for Marketing Authorization Holder is listed in leaflet with the product.